Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Summer 2025 - Vaccines
Download Issue
Share
Up Front
Publisher's Corner
Advances in Vaccine Technology Continue to Save Lives
By Patrick M. Schmidt
Features
Can Inverse Vaccines Cure Autoimmunity?
By
Rachel Maier, MS
Myths & Facts: Rheumatoid Arthritis
By
Trudie Mitschang
STIs: New Vaccines and Expanding Recommendations
By
Amy Scanlin, MS
The Physician Shortage and Its Effects on Healthcare
By
Ronale Tucker Rhodes, MS
Update on Measles
By
Jim Trageser
Travel Vaccines: What’s Needed and Why?
By
Diane L.M. Cook
BioTrends Watch
Washington Report
New Data Show One in 31 Kids Has Autism
University of Toledo Awarded Funds to Explore Immune Response to Oral Thrush
Draft Budget Proposal Would Cut HHS Federal Health Programs by One-Third
HHS and NIH Invest in Universal Vaccine Platform for Pandemic-Prone Viruses
Reimbursement FAQs
Proposed Spending for 2025 and 2026
Healthcare Management
Adopting a Social Media Policy in Healthcare Settings
Industry News
FDA Accelerates Approval for Rare Kidney Disease
COVID-19 May Increase IVIG-Resistance in Kids Prior to Developing Kawasaki Disease
Activating B Cells Key to TIL Cancer Therapy Effectiveness
Flebogamma (IVIG) Effective in Treating Post-Polio Syndrome
FDA Approves New Drug to Treat UTIs
New Personalized Vaccine May Treat Pancreatic Cancer
Vaccine Shows Promise In Stopping Plaque Buildup in Arteries
Aspirin May Prevent Metastasis of Cancer
BioFocus
Industry Insight
Avian Flu and Human Vaccines: Where Things Stand
By Keith Berman, MPH, MBA
Patient Profile
Measles: A Patient’s Perspective
By Trudie Mitschang
Physician Profile
Measles: A Physician’s Perspective
By Trudie Mitschang
BioSources
BioTech
Utilizing AI in the Clinical Setting